FDA Watch: Agency Resounds the Alarm on Biotin Test Interference

FDA Watch: Agency Resounds the Alarm on Biotin Test Interference

In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The update reiterates the warning

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here